**Core Concept**
Fusion inhibitors are a class of antiretroviral drugs that prevent the fusion of the human immunodeficiency virus (HIV) with host cell membranes, thereby inhibiting viral entry into the host cells. This mechanism is crucial in the treatment of HIV infection.

**Why the Correct Answer is Right**
Fusion inhibitors specifically target the gp41 protein, which is responsible for the fusion of the viral envelope with the host cell membrane. By binding to gp41, fusion inhibitors prevent the formation of the six-helix bundle, a conformational change necessary for viral entry. This results in the inhibition of viral replication, making fusion inhibitors an essential component of HIV treatment regimens.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the mechanism of action of fusion inhibitors. While certain antiretroviral drugs may target viral entry, they do not specifically inhibit the fusion process.
**Option B:** This option is incorrect because it is a characteristic of another class of antiretroviral drugs, not fusion inhibitors. Protease inhibitors target the viral protease enzyme, which is essential for viral replication.
**Option C:** This option is incorrect because it is a characteristic of another class of antiretroviral drugs, not fusion inhibitors. Nucleoside reverse transcriptase inhibitors (NRTIs) target the viral reverse transcriptase enzyme, which is essential for viral replication.

**Clinical Pearl / High-Yield Fact**
Fusion inhibitors, such as enfuvirtide, are particularly useful in treatment-experienced patients with multidrug-resistant HIV. They can be used in combination with other antiretroviral drugs to achieve viral suppression and improve patient outcomes.

**Correct Answer: C. Enfuvirtide**